Cytek Biosciences (CTKB) Common Equity (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Common Equity came in at $327.6 million in Q1 2026, down 13.69% YoY from $379.6 million in Q1 2025, and down 4.12% on a QoQ basis from $341.7 million in Q4 2025.
Cytek Biosciences (CTKB) Common Equity (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Common Equity data on file, last reported at $327.6 million in Q1 2026.
- Quarterly Common Equity fell 13.69% year-over-year to $327.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $327.6 million (down 13.69% YoY) and the FY2025 annual result came in at $341.7 million, down 13.64% from the prior year.
- Common Equity retreated to $327.6 million in Q1 2026, from $341.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $425.5 million in Q4 2022 to a low of $327.6 million in Q1 2026.
- A 5-year average of $393.2 million and a median of $393.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity jumped 40644.2% — and 2026, when it fell 13.69%.
- Tracing CTKB's Common Equity over 5 years: stood at $425.5 million in 2022, then decreased by 7.63% to $393.1 million in 2023, then grew by 0.68% to $395.7 million in 2024, then dropped by 13.64% to $341.7 million in 2025, then fell by 4.12% to $327.6 million in 2026.
- The last three Common Equity figures came in at $327.6 million (Q1 2026), $341.7 million (Q4 2025), and $378.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 321.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 321.95 Mn |
| Mar 31, 2026 | 327.64 Mn |
| Dec 31, 2025 | 341.74 Mn |
| Sep 30, 2025 | 378.57 Mn |
| Jun 30, 2025 | 377.56 Mn |
| Mar 31, 2025 | 379.62 Mn |
| Dec 31, 2024 | 395.74 Mn |
| Sep 30, 2024 | 385.46 Mn |
| Jun 30, 2024 | 389.12 Mn |
| Mar 31, 2024 | 392.61 Mn |
| Dec 31, 2023 | 393.06 Mn |
| Sep 30, 2023 | 415.52 Mn |
| Jun 30, 2023 | 424.18 Mn |
| Mar 31, 2023 | 423.46 Mn |
| Dec 31, 2022 | 425.55 Mn |
| Sep 30, 2022 | 416.51 Mn |
| Jun 30, 2022 | 411.13 Mn |
| Mar 31, 2022 | 407.44 Mn |
| Dec 31, 2021 | 405.39 Mn |
| Sep 30, 2021 | 403.20 Mn |